Literature DB >> 11478313

Use of historical control data in carcinogenicity studies in rodents.

J K Haseman1, J Huff, G A Boorman.   

Abstract

This paper considers the use of historical control data in the evaluation of tumor incidences from carcinogenicity studies in rodents. Although the most appropriate control group for interpretative purposes is always the concurrent control, there are instances in which the use of historical control information can aid an investigator in the overall evaluation of tumor incidence data. One example is rare tumors; another is a tumor that shows a marginally significant result relative to concurrent controls. However, before historical control data can be used in a formal testing framework, a number of important issues must first be considered. The nomenclature conventions and diagnostic criteria for each study should be identical to insure unambiguous identification of all relevant tumors in the historical control database. Criteria should be established that will aid in determining whether a particular study should be included in the database. This will assure a homogeneous set of studies upon which to base statistical comparisons. Since study-to-study variability in tumor rates may exceed what would be expected by chance alone, these sources of variability should be identified and controlled. Finally, statistical procedures should be employed that adjust for extra-binomial variability. This paper also summarizes tumor incidence data from untreated Fischer 344 rats and B6C3F1 mice in the National Toxicology Program (NTP) historical control database. All studies in the database are of two years duration, and all neoplasms occurring with a frequency of 0.5% or more are reported.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 11478313     DOI: 10.1177/019262338401200203

Source DB:  PubMed          Journal:  Toxicol Pathol        ISSN: 0192-6233            Impact factor:   1.902


  30 in total

1.  Bayesian analysis of mutational spectra.

Authors:  D B Dunson; K R Tindall
Journal:  Genetics       Date:  2000-11       Impact factor: 4.562

Review 2.  [Evaluation of cancer risk through genetic analysis?].

Authors:  A Luz
Journal:  Strahlenther Onkol       Date:  1997-09       Impact factor: 3.621

3.  DETERMINING DISEASE CAUSALITY FROM EXPERIMENTAL TOXICOLOGY STUDIES.

Authors:  Ronald L Melnick; John R Bucher
Journal:  J Law Policy       Date:  2005

4.  Incorporating Historical Control Data When Comparing Tumor Incidence Rates.

Authors:  Shyamal D Peddada; Gregg E Dinse; Grace E Kissling
Journal:  J Am Stat Assoc       Date:  2007-01-01       Impact factor: 5.033

5.  The chemotherapeutic potential of glycol alkyl ethers: structure-activity studies of nine compounds in a Fischer-rat leukemia transplant model.

Authors:  M P Dieter; C W Jameson; R R Maronpot; R Langenbach; A G Braun
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

6.  Lewis rats of the inbred strain LEW/Han: life expectancy, spectrum and incidence of spontaneous neoplasms.

Authors:  A Baum; G Pohlmeyer; K G Rapp; F Deerberg
Journal:  Exp Toxicol Pathol       Date:  1995-01

7.  Detection and identification of activated oncogenes in spontaneously occurring benign and malignant hepatocellular tumors of the B6C3F1 mouse.

Authors:  S H Reynolds; S J Stowers; R R Maronpot; M W Anderson; S A Aaronson
Journal:  Proc Natl Acad Sci U S A       Date:  1986-01       Impact factor: 11.205

8.  Two-year carcinogenicity study of 6-mercaptopurine in F344 rats.

Authors:  A Maekawa; T Nagaoka; H Onodera; Y Matsushima; A Todate; M Shibutani; H Ogasawara; Y Kodama; Y Hayashi
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

9.  Spontaneous Adenosquamous Carcinoma with Rapid Growth and EMT-like Changes in the Mammary Gland of a Young Adult Female BALB/c Mouse.

Authors:  Katsumi Takaba; Teruyoshi Imada; Shigehisa Katsumata; Hiroshi Okumura; Sachiko Iwamoto; Yui Suzuki; Minami Imaizumi; Kensuke Myojo; Chie Takada; Naoya Kimoto; Koji Saeki; Itaru Yamaguchi
Journal:  J Toxicol Pathol       Date:  2012-12-20       Impact factor: 1.628

10.  The Weight of Evidence Does Not Support the Listing of Styrene as "Reasonably Anticipated to be a Human Carcinogen" in NTP's Twelfth Report on Carcinogens.

Authors:  Lorenz R Rhomberg; Julie E Goodman; Robyn L Prueitt
Journal:  Hum Ecol Risk Assess       Date:  2013-01-02       Impact factor: 5.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.